secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0000875045-23-000024
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen shareholders elect directors, ratify auditor, approve say-on-pay at 2023 annual meeting
--------------------------------------------------------------------------------

- Seven incumbent directors re-elected; Susan K. Langer elected with 64M for, 46.6M against, 8.5M abstentions.
- Ratification of PricewaterhouseCoopers as independent auditor for FY2023 approved with 123.4M for, 4.3M against.
- Advisory vote on executive compensation approved with 82.6M for, 36.3M against.
- Advisory frequency vote set at every one year with 115.8M votes for 1-year.
- Broker non-votes of 8.7M shares reported on director elections and compensation items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/0000875045-23-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000087504523000024/biib-20230626.htm
  HTML page:      https://secwatch.observer/filing/0000875045-23-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer